Consuming a primarily plant-based diet may be associated with better cancer-specific health outcomes among men with prostate cancer, according to a study published online May 1 in JAMA Network Open.
May 6, 2024
0
1
The overall risk for cancer is not increased for children born after medically assisted reproduction (MAR), according to a study published online May 2 in JAMA Network Open.
May 6, 2024
0
0
Most patients with brain tumors receive one of two types of radiation: external beam radiation, in which the tumor is treated over the course of several weeks, or radiosurgery, in which patients receive a high dose of radiation ...
May 6, 2024
0
0
Part of the reproductive system, the cervix connects the vagina to the uterus, also known as the womb. By collecting cervical cells (called the Pap smear after the scientist who pioneered the screening test in the mid-1900s), ...
May 6, 2024
0
0
One of the earliest descriptions of someone with cancer comes from the fourth century BC. Satyrus, tyrant of the city of Heracleia on the Black Sea, developed a cancer between his groin and scrotum. As the cancer spread, ...
May 5, 2024
0
13
A personalized mRNA vaccine to treat melanoma has now reached late-stage trials in the UK. This is just the latest step in improving the cure rate of cancer.
May 4, 2024
0
0
CD7 expression is associated with poorer outcomes in patients with newly diagnosed acute myeloid leukemia (AML), according to a study published online April 11 in the British Journal of Haematology.
May 4, 2024
0
7
The journey of cancer genomic medicine (CGM) began in the 1980s, with the discovery of various genomic and epigenomic alterations in cancer cells from various countries including Japan. This led to the development of molecular ...
May 4, 2024
0
0
The Wistar Institute assistant professor Filippo Veglia, Ph.D., and team, have discovered a key mechanism of how glioblastoma—a serious and often fatal brain cancer—suppresses the immune system so that the tumor can grow ...
May 3, 2024
0
50
A drug that targets a protein known as phosphatidylserine boosted the response rate for hepatocellular carcinoma (HCC) patients receiving immunotherapy without compromising their safety, according to results of a phase two ...
May 3, 2024
0
52
